Connection
Emily Farrow to Phosphates
This is a "connection" page, showing publications Emily Farrow has written about Phosphates.
|
|
Connection Strength |
|
|
|
|
|
0.762 |
|
|
|
-
Farrow EG, White KE. Recent advances in renal phosphate handling. Nat Rev Nephrol. 2010 Apr; 6(4):207-17.
Score: 0.374
-
Clinkenbeard EL, Farrow EG, Summers LJ, Cass TA, Roberts JL, Bayt CA, Lahm T, Albrecht M, Allen MR, Peacock M, White KE. Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice. J Bone Miner Res. 2014 Feb; 29(2):361-9.
Score: 0.123
-
Smith RC, O'Bryan LM, Farrow EG, Summers LJ, Clinkenbeard EL, Roberts JL, Cass TA, Saha J, Broderick C, Ma YL, Zeng QQ, Kharitonenkov A, Wilson JM, Guo Q, Sun H, Allen MR, Burr DB, Breyer MD, White KE. Circulating aKlotho influences phosphate handling by controlling FGF23 production. J Clin Invest. 2012 Dec; 122(12):4710-5.
Score: 0.113
-
Farrow EG, Imel EA, White KE. Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and aKlotho). Best Pract Res Clin Rheumatol. 2011 Oct; 25(5):735-47.
Score: 0.105
-
Rhee Y, Bivi N, Farrow E, Lezcano V, Plotkin LI, White KE, Bellido T. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Bone. 2011 Oct; 49(4):636-43.
Score: 0.026
-
Dumitrescu CE, Kelly MH, Khosravi A, Hart TC, Brahim J, White KE, Farrow EG, Nathan MH, Murphey MD, Collins MT. A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features. Osteoporos Int. 2009 Jul; 20(7):1273-8.
Score: 0.021
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|